HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amancio Carnero Selected Research

neurabin

1/2021Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells.
12/2017Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.
12/2016The Cytoskeletal Adapter Protein Spinophilin Regulates Invadopodia Dynamics and Tumor Cell Invasion in Glioblastoma.
7/2013Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma.
8/2011Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation.
6/2011Spinophilin loss contributes to tumorigenesis in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amancio Carnero Research Topics

Disease

87Neoplasms (Cancer)
04/2022 - 06/2003
15Carcinoma (Carcinomatosis)
10/2020 - 08/2007
14Carcinogenesis
11/2020 - 08/2005
10Sarcoma (Soft Tissue Sarcoma)
08/2021 - 05/2005
9Adenocarcinoma
01/2019 - 03/2007
8Breast Neoplasms (Breast Cancer)
10/2020 - 03/2007
8Neoplasm Metastasis (Metastasis)
10/2020 - 11/2012
7Lung Neoplasms (Lung Cancer)
03/2020 - 01/2012
6Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 07/2013
6Hematologic Neoplasms (Hematological Malignancy)
11/2016 - 04/2007
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 08/2013
5Adenocarcinoma of Lung
01/2019 - 06/2014
4Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 06/2019
4Inflammation (Inflammations)
10/2020 - 01/2013
3Colonic Neoplasms (Colon Cancer)
01/2018 - 12/2014
3Chronic Obstructive Pulmonary Disease (COPD)
12/2016 - 02/2013
3Multiple Myeloma
06/2015 - 08/2013
3Pathologic Processes
09/2014 - 01/2012
2Rectal Neoplasms (Rectal Cancer)
01/2020 - 08/2018
2Laryngeal Neoplasms (Laryngeal Cancer)
05/2016 - 05/2015
2Lymphoma (Lymphomas)
01/2013 - 11/2007
2Melanoma (Melanoma, Malignant)
10/2007 - 06/2003
1Hypoxia (Hypoxemia)
07/2021
1Retinoblastoma (Glioblastoma, Retinal)
01/2021
1Malignant Mesothelioma
01/2020
1Frailty
01/2020
1Glioma (Gliomas)
01/2019

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
08/2021 - 06/2003
16Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2012
13Membrane Proteins (Integral Membrane Proteins)IBA
08/2018 - 08/2007
10Messenger RNA (mRNA)IBA
08/2021 - 11/2007
9Pharmaceutical PreparationsIBA
08/2018 - 05/2005
7MicroRNAs (MicroRNA)IBA
11/2020 - 01/2012
6PlatinumIBA
08/2021 - 05/2007
6EnzymesIBA
01/2021 - 11/2007
6neurabinIBA
01/2021 - 06/2011
6Phosphotransferases (Kinase)IBA
08/2017 - 01/2010
5Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 05/2005
5proto-oncogene proteins pimIBA
08/2017 - 08/2012
4Cisplatin (Platino)FDA LinkGeneric
08/2018 - 05/2007
4CarcinogensIBA
11/2016 - 03/2007
4Biological ProductsIBA
09/2014 - 09/2005
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 12/2010
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 09/2009
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 12/2014
3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2018 - 01/2013
3Bortezomib (Velcade)FDA Link
08/2018 - 06/2015
3Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2015 - 05/2005
2Transcription Factors (Transcription Factor)IBA
08/2021 - 09/2008
2HoloenzymesIBA
05/2021 - 01/2021
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2021 - 09/2009
2Cadherins (E-Cadherin)IBA
03/2020 - 01/2018
2olaparibIBA
01/2020 - 08/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 02/2007
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2019 - 08/2008
2Proteasome InhibitorsIBA
08/2018 - 06/2015
2NAD (NADH)IBA
01/2018 - 11/2017
2Adenosine Triphosphate (ATP)IBA
12/2017 - 12/2015
2ParaffinIBA
01/2017 - 12/2014
2LigandsIBA
12/2016 - 05/2007
2Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2016 - 05/2016
2Dasatinib (BMS 354825)FDA Link
11/2016 - 05/2016
2Estrogen ReceptorsIBA
12/2014 - 03/2007
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2014 - 01/2013
2Protein Isoforms (Isoforms)IBA
08/2012 - 09/2009
2Estrogen Receptor alphaIBA
12/2008 - 03/2007
2AminesIBA
10/2008 - 05/2007
2TrabectedinIBA
02/2007 - 05/2005
1Therapeutic UsesIBA
01/2022
1SenotherapeuticsIBA
01/2022
1CateninsIBA
08/2021
1Oxygen (Dioxygen)IBA
07/2021
1NestinIBA
01/2021
1Protein Phosphatase 1IBA
01/2021
1Myosin-Light-Chain PhosphataseIBA
11/2020
1Small Interfering RNA (siRNA)IBA
11/2020
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
03/2020
1AZD1208IBA
01/2020
1Complement System Proteins (Complement)IBA
01/2020
1InterleukinsIBA
01/2020
1Plasminogen Activator Inhibitor 1IBA
01/2020
1Sirolimus (Rapamycin)FDA Link
01/2020
1MaravirocFDA Link
01/2020
1Nicotinamide PhosphoribosyltransferaseIBA
01/2019
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2019
1Gefitinib (Iressa)FDA Link
01/2019
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2019
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019
1Anaplastic Lymphoma KinaseIBA
01/2019
1Phosphatidic Acids (Phosphatidic Acid)IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1phospholipase D2IBA
01/2019
11-dodecylpyridoxal (PLD)IBA
01/2019
1resorcinol (resorcin)IBA
01/2019

Therapy/Procedure

35Therapeutics
04/2022 - 11/2007
14Drug Therapy (Chemotherapy)
04/2022 - 11/2007
9Radiotherapy
04/2022 - 01/2013
3Adjuvant Chemotherapy
01/2020 - 12/2014
1Operative Surgical Procedures
01/2020